Fri, May 25, 2012
Thu, May 24, 2012

Liav Abraham Maintained (TEVA) at Strong Buy with Decreased Target to $49 on, May 25th, 2012

Liav Abraham of Citigroup, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Decreased Target from $55 to $49 on, May 25th, 2012.

Liav, nor any peers, have made any analyst calls on TEVA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30


Similar Stocks and Investing Publications